SEGMENT REPORTING

6 Months Ended

Jun. 30, 2020

Segment Reporting [Abstract]

SEGMENT REPORTING

16. SEGMENT REPORTING

Reportable segments are presented in a manner consistent with the internal reporting provided to the chief operating decision maker (CODM). In April 2020, the Company designated its Chief Executive Officer (CEO) to be its Chief Operating Decision Maker (CODM) and dissolved the function of the Office of the Chief Executive consisting of the President, Chief Operating Officer, and Chief Financial Officer which previously acted as its CODM.

The CODM allocates resources to and assesses the performance of each segment using information about its revenue and operating income (loss). These measures are presented in the following tables (in thousands). Asset information by segment is not presented, as this measure is not used by the CODM to assess the segment’s performance.

	For the Three Months Ended						For the Six Months Ended
	June 30,						June 30,
	2020			2019			2020			2019
Net revenues by segment:
Regenerative medicine	$	944		$	504		$	1,372		$	801
Contract services		1,322			822			1,827			1,990
Total net revenues	$	2,266		$	1,326		$	3,199		$	2,791
Net loss by segment:
Regenerative medicine	$	(12,567	)	$	(22,572	)	$	(25,270	)	$	(47,781	)
Contract services		(110	)		(220	)		(447	)		(584	)
Total net loss	$	(12,677	)	$	(22,792	)	$	(25,717	)	$	(48,365	)